Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-26

Clinical Trial Update: Semaglutide for Helping Opioid Recovery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating semaglutide for opioid use disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • semaglutide (semaglutide)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Opioid Use Disorder | Phase 2 | Status: RECRUITING